(最終更新日:2025-07-15 17:30:06)
  キクチ エイジ   KIKUCHI EIJI
  菊地栄次
   所属   医学部医学科 腎泌尿器外科学
   職種   主任教授
■ 学術雑誌
1. その他  Editorial Comment to "Impact of Early Detection and Varying Duration of Chemoprophylaxis on Venous Thromboembolism After Robot-Assisted Radical Cystectomy" 2025/07 Link
2. 原著  Factors associated with primary resistance to enfortumab vedotin in previously treated patients with metastatic urothelial carcinoma: a multicenter retrospective study 2025/07
3. 原著  Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study 2025/06 Link
4. 原著  Prevalence and factors associated with premature ejaculation in Japan: First nationwide cross-sectional survey by the Japanese Society for Sexual Medicine 2025/06 Link
5. その他  The Dublin International Society of Urological Pathology (ISUP) consensus conference on best practice recommendations on the pathology of urachal neoplasms 2025/06 Link
全件表示(165件)
■ 著書
1. 部分執筆  Ⅱ疾患 03 腎盂・尿管癌「専攻医がおさえておきたい泌尿器疾患 TOP30 2025」 2025/04
2. 部分執筆  Ⅱ疾患 02腎細胞癌(stage Ⅳ)「専攻医がおさえておきたい泌尿器疾患 TOP30 2025」 2025/04
3. 部分執筆  膀胱腫瘍「今日の治療指針(2025年度版)」 2025/01 Link
4. 部分執筆  9. 腎移植術(自家・生体・献腎)「2023 後期研修医がおさえておきたい泌尿器手術 TOP30」 2023/04
5. 部分執筆  性機能障害(勃起障害)「今日の治療指針 私はこう治療している」 2022/01
全件表示(10件)
■ 学会発表
1. Avelumab maintenance therapy in patients (pts) with advanced urothelial carcinoma (UC) in Japan: Subgroup analyses by best overall response (BOR) to prior platinum-based chemotherapy (PBC) in a post-marketing surveillance (PMS) population (ポスター,一般) 2025/06/02
2. Effectiveness and treatment patterns in patients with advanced urothelial carcinoma receiving avelumab first-line (1L) maintenance in Japan: JAVEMACS (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2025/04/19
3. Efficacy and safety of nadofaragene firadenovec for BCG-unresponsive non-muscle-invasive bladder cancer: initial results from an ongoing Japanese phase 3 trial (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2025/04/19
4. EV-302: enfortumab vedotin + pembrolizumab (EV+P) vs chemotherapy (chemo) in locally advanced or metastatic urothelial carcinoma (la/mUC) – updated analysis (口頭発表,シンポジウム・ワークショップ・パネルディスカッション等) 2025/04/19
5. Investigation of the prevalence and risk factors of delayed ejaculation: Insights from a nationwide internet-based survey on male sexual dysfunction in Japan (口頭発表,一般) 2025/04/19
全件表示(339件)